{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:48:45Z","timestamp":1770137325979,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Wnt\/\u03b2-catenin signaling pathway is closely related to the pathogenesis Osteonecrosis of the femoral head (ONFH). \u03b2-catenin, as a major component of Wnt signaling pathway, plays a vital role in the proliferation of osteoblasts. But the effect of altering \u03b2-catenin level on the early diagnosis and staging of ONFH has not been studied. Our purpose is to investigate the role of \u03b2-catenin level in the progress of ONFH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>One hundred and one patients with three stages of ONFH and fifty healthy\u00a0controls\u00a0were recruited between May 2016 and November 2016. We divided the patients into 32 cases of stage II, 41 cases of stage III and 28 cases of stage IV according to the Association Research Circulation Osseous (ARCO) classification. We evaluated the clinical bone histomorphology, expression position and level of \u03b2-catenin as well as the plasma \u03b2-catenin level. We investigated the level of \u03b2-catenin from the serum and tissue samples using ELISA and Western Blot assay. We also evaluated the expression of \u03b2-catenin in bone tissue by immunohistochemistry. Data were analyzed by independent t-test and ANOVA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that the mean (\u00b1\u2009SD) serum level of \u03b2-catenin was 66.99\u2009\u00b1\u20093.032\u00a0ng\/ml in the ONFH patients, which was higher than 20.14\u2009\u00b1\u20091.715\u00a0ng\/ml observed in the control group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Moreover, the \u03b2-catenin levels were 49.30\u2009\u00b1\u20094.649\u00a0ng\/ml, 72.54\u2009\u00b1\u20094.864\u00a0ng\/ml and 79.10\u2009\u00b1\u20094.773\u00a0ng\/ml in the ONFH patients with ARCO stage II, stage III and stage IV respectively, showing significant difference among them (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). We also found that the area under the curve (AUC) calculated by ROC curve analysis to determine the values for \u03b2-catenin levels in ONFH compared with those in the control group was 0.9358 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), where the sensitivity was 77.23% and specificity was 98.00%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results indicate that the increased \u03b2-catenin may play a vital role in the progress of ONFH and the level of \u03b2-catenin is correlated with ARCO stages. The cut-off concentration may be used as one of the sensitive marks to assess the disease process of ONFH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-022-05399-2","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:02:59Z","timestamp":1652166179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum \u03b2-catenin changes vary among different stages of osteonecrosis of the femoral head: an exploratory biomarker study"],"prefix":"10.1186","volume":"23","author":[{"given":"Junyuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiushi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"12","key":"5399_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1166\/jbt.2015.1399","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu Y, Zhou G, et al. Fibular allograft for osteonecrosis prevention in the management of femoral neck fractures: clinical outcome and biomechanical evaluation. J Biomater Tissue Eng. 2015;5(12):937\u201341.","journal-title":"J Biomater Tissue Eng"},{"issue":"1","key":"5399_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/os.12302","volume":"9","author":"Microsurgery Department of the Orthopedics Branch of the Chinese Medical Doctor AGroup from the O","year":"2017","unstructured":"Microsurgery Department of the Orthopedics Branch of the Chinese Medical Doctor AGroup from the O, Bone Defect Branch of the Chinese Association of R, et al. Chinese guideline for the diagnosis and treatment of osteonecrosis of the femoral head in adults. Orthop Surg. 2017;9(1):3\u201312.","journal-title":"Orthop Surg"},{"issue":"5","key":"5399_CR3","first-page":"1117","volume":"88","author":"MA Mont","year":"2006","unstructured":"Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006;88(5):1117\u201332.","journal-title":"J Bone Joint Surg Am"},{"issue":"21","key":"5399_CR4","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.4103\/0366-6999.168017","volume":"128","author":"DW Zhao","year":"2015","unstructured":"Zhao DW, Yu M, Hu K, et al. prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population: results from a nationally representative survey. Chin Med J. 2015;128(21):2843\u201350.","journal-title":"Chin Med J"},{"issue":"3","key":"5399_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00264-008-0518-y","volume":"33","author":"V Gangji","year":"2009","unstructured":"Gangji V, Rooze M, Maertelaer VD, et al. Inefficacy of the cementation of femoral head collapse in glucocorticoid-induced osteonecrosis. Int Orthop. 2009;33(3):639\u201342.","journal-title":"Int Orthop"},{"issue":"4","key":"5399_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","volume":"66","author":"JH Wessel","year":"2008","unstructured":"Wessel JH, Dodson TB, Zavras AI. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J Oral Maxillofac Surg. 2008;66(4):625\u201331.","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"5399_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gendis.2015.12.004","volume":"3","author":"MK Mohammed","year":"2016","unstructured":"Mohammed MK, Shao C, Jing W, et al. Wnt\/\u03b2-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis. 2016;3(1):11\u201340.","journal-title":"Genes Dis"},{"issue":"1","key":"5399_CR8","first-page":"11928","volume":"7","author":"J Pei","year":"2017","unstructured":"Pei J, Fan L, Nan K, et al. Excessive activation of TLR4\/NF-\u03baB interactively suppresses the canonical Wnt\/\u03b2-catenin pathway and induces SANFH in SD rats. Rep. 2017;7(1):11928.","journal-title":"Rep"},{"issue":"2","key":"5399_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12020-015-0747-y","volume":"52","author":"Z Yu","year":"2016","unstructured":"Yu Z, Fan L, Li J, et al. Lithium prevents rat steroid-related osteonecrosis of the femoral head by \u03b2-catenin activation. Endocrine. 2016;52(2):380\u201390.","journal-title":"Endocrine"},{"issue":"10","key":"5399_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.17219\/acem\/104533","volume":"28","author":"Fuwen","year":"2019","unstructured":"Fuwen, Zhang, Kun, et al. miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt\/\u03b2-catenin signaling pathway. Adv Clin Exp Med. 2019;28(10):1293\u2013300.","journal-title":"Adv Clin Exp Med"},{"key":"5399_CR11","volume-title":"Bone Circulation & Vascularization in Normal & Pathological Conditions","author":"JWM Gardeniers","year":"1993","unstructured":"Gardeniers JWM. The Arco Perspective for Reaching One Uniform Staging System of Osteonecrosis. In: Bone Circulation & Vascularization in Normal & Pathological Conditions. 1993."},{"key":"5399_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2018.09.018","volume":"490","author":"SD Gong","year":"2019","unstructured":"Gong SD, Chen XJ, Chen ZQ, et al. Elevated plasma cartilage oligomeric matrix protein (COMP) level are associated with the progression of non-traumatic osteonecrosis of femoral head. Clinica Chimica Acta. 2019;490:214\u201321.","journal-title":"Clinica Chimica Acta"},{"issue":"7","key":"5399_CR13","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00264-018-3979-7","volume":"42","author":"XJ Chen","year":"2018","unstructured":"Chen XJ, Yang F, Chen ZQ, et al. Association of reduced sclerostin expression with collapse process in patients with osteonecrosis of the femoral head. Int Orthop. 2018;42(7):1675\u201382.","journal-title":"Int Orthop"},{"key":"5399_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.biopha.2019.01.013","volume":"111","author":"M He","year":"2019","unstructured":"He M, Gong SD, Chen XJ, et al. Plasma C-terminal cross-linking telopeptide of type II collagen as a biomarker in advanced stages of femoral head osteonecrosis. Biomed Pharmacother. 2019;111:1213\u201320.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"5399_CR15","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1002\/jcp.26265","volume":"233","author":"M Majidinia","year":"2018","unstructured":"Majidinia M, Aghazadeh J, Jahanban-Esfahlani R, et al. The roles of Wnt\/beta-catenin pathway in tissue development and regenerative medicine. J Cell Physiol. 2018;233(8):5598\u2013612.","journal-title":"J Cell Physiol"},{"issue":"12","key":"5399_CR16","doi-asserted-by":"publisher","first-page":"a007997","DOI":"10.1101\/cshperspect.a007997","volume":"4","author":"JB Regard","year":"2012","unstructured":"Regard JB, Zhong Z, Williams BO, et al. Wnt signaling in bone development and disease: making stronger bone with Wnts. Cold Spring Harb Perspect Biol. 2012;4(12):a007997.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"5399_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass","year":"2005","unstructured":"Glass DA, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005;8(5):751\u201364.","journal-title":"Dev Cell"},{"issue":"2","key":"5399_CR18","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jcb.21651","volume":"104","author":"M Eijken","year":"2008","unstructured":"Eijken M, Meijer IM, Westbroek I, et al. Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner. J Cell Biochem. 2008;104(2):568\u201379.","journal-title":"J Cell Biochem"},{"issue":"12","key":"5399_CR19","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s10067-014-2607-1","volume":"33","author":"E Mutijima","year":"2014","unstructured":"Mutijima E, de Maertelaer V, Deprez M, et al. The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution. Clin Rheumatol. 2014;33(12):1791\u20135.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"5399_CR20","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/jemt.23379","volume":"82","author":"L Rony","year":"2019","unstructured":"Rony L, Perrot R, Hubert L, et al. Osteocyte staining with rhodamine in osteonecrosis and osteoarthritis of the femoral head. Microsc Res Tech. 2019;82(12):2072\u20138.","journal-title":"Microsc Res Tech"},{"issue":"5","key":"5399_CR21","doi-asserted-by":"publisher","first-page":"e96361","DOI":"10.1371\/journal.pone.0096361","volume":"9","author":"C Wang","year":"2014","unstructured":"Wang C, Wang X, Xu XL, et al. Bone microstructure and regional distribution of osteoblast and osteoclast activity in the osteonecrotic femoral head. Plos One. 2014;9(5):e96361.","journal-title":"Plos One"},{"key":"5399_CR22","doi-asserted-by":"crossref","unstructured":"Zhang C, Zou YL, MA J, et al. Apoptosis associated with Wnt\/\u03b2-catenin pathway leads to steroid-induced avascular necrosis of femoral head. BMC Musculoskelet Disord. 2015;16(1):132.","DOI":"10.1186\/s12891-015-0606-2"},{"issue":"1","key":"5399_CR23","doi-asserted-by":"publisher","first-page":"11928","DOI":"10.1038\/s41598-017-12196-8","volume":"7","author":"J Pei","year":"2017","unstructured":"Pei J, Fan L, Nan K, et al. Excessive activation of TLR4\/NF-kappaB interactively suppresses the canonical Wnt\/beta-catenin pathway and induces SANFH in SD rats. Sci Rep. 2017;7(1):11928.","journal-title":"Sci Rep"},{"issue":"1","key":"5399_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.yexmp.2016.07.009","volume":"101","author":"G Liu","year":"2016","unstructured":"Liu G, Luo G, Bo Z, et al. Impaired osteogenic differentiation associated with connexin43\/microRNA-206 in steroid-induced avascular necrosis of the femoral head. Exp Mol Pathol. 2016;101(1):89\u201399.","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"5399_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.orthres.2004.12.006","volume":"23","author":"RA Magnussen","year":"2010","unstructured":"Magnussen RA, Guilak F, Vail TP. Cartilage degeneration in post-collapse cases of osteonecrosis of the human femoral head: altered mechanical properties in tension, compression, and shear. J Orthop Res. 2010;23(3):576\u201383.","journal-title":"J Orthop Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05399-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-022-05399-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05399-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:08:02Z","timestamp":1652166482000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-022-05399-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5399"],"URL":"https:\/\/doi.org\/10.1186\/s12891-022-05399-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"16 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the study involving human participants were approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou University of Chinese Medicine and were conducted in compliance with the Declaration of Helsinki. All the patients and the healthy volunteers signed an informed consent for testing and use of de-identified data. All experiments on humans and\/or the use of human tissue samples were performed\u00a0in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}